Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma

J. M. Connors, W. Jurczak, D. J. Straus, S. M. Ansell, W. S. Kim, A. Gallamini, A. Younes, S. Alekseev, A. Illés, M. Picardi, E. Lech-Maranda, Y. Oki, T. Feldman, P. Smolewski, K. J. Savage, N. L. Bartlett, J. Walewski, R. Ramchandren, P. L. Zinzani, D. CunninghamA. Rosta, N. C. Josephson, E. Song, J. Sachs, R. Liu, H. A. Jolin, D. Huebner, J. Radford, Rebort Chen, ECHELON-1 Study Group, Tzeon-Jye Chiou

Research output: Contribution to journalArticlepeer-review

572 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry